Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    NIAID | Recruiting | Exclude Unknown | allergy OR asthma OR diabetes OR transplant OR multiple sclerosis OR psoriatic arthritis OR lupus
Show Display Options
Rank Status Study
21 Recruiting Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Conditions: Liver Transplant Recipient;   Living Donor (of the Respective Liver Transplant Recipient)
Interventions: Biological: darTregs;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Immunosuppression (IS) Withdrawal;   Procedure: Study Mandated Procedures
22 Recruiting Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways
Condition: Atopic Dermatitis
23 Recruiting Impact of Vaccination on Th2 Immunity in Infancy
Condition: Food Hypersensitivity
Interventions: Procedure: Skin prick allergen test;   Procedure: Blood draw
24 Recruiting B Cell Induction in Pediatric Lung Transplantation
Condition: Lung Transplant
Interventions: Biological: Rituximab (Rituxan®);   Biological: Placebo
25 Recruiting Fel d 1 Peptide Immunotherapy Clinical Trial
Conditions: Cat Allergy;   Cat Hypersensitivity
Interventions: Drug: Cat-PAD;   Drug: Placebo
26 Recruiting BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Condition: Kidney Transplantation
Interventions: Biological: Antithymocyte globulin (ATG);   Drug: Fludarabine;   Drug: Low dose Pre-transplant cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Methylprednisolone;   Biological: Bone Marrow;   Drug: MESNA;   Drug: Mycophenolate mofetil (MMF);   Drug: Prednisone;   Drug: Filgrastim;   Drug: High dose post-transplant cyclophosphamide
27 Recruiting Impact of Allo- and Autoantibodies on Chronic Cardiac Allograft Function
Conditions: Pediatric Heart Transplantation;   Pediatric Heart Transplant Recipients
28 Recruiting Molecular Basis of Food Allergy
Conditions: Food Allergy;   Eosinophilic Esophagitis
29 Recruiting Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Condition: Liver Transplantation
Interventions: Biological: Anti-Thymocyte Globulin - Rabbit;   Biological: darTreg Infusion;   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Prednisone;   Drug: Acetaminophen;   Drug: Diphenhydramine;   Drug: Anti-Infective Prophylaxis;   Procedure: Leukapheresis;   Procedure: Blood draws;   Procedure: Liver biopsies;   Procedure: Liver transplantation
30 Recruiting Investigate the Effect of the CREON2000A on Asthma Control in Children With Mild to Moderate Persistent Allergic Asthma
Condition: Allergic Asthma
Interventions: Device: CREON2000A;   Device: Sham
31 Recruiting A Cohort Study of Operationally Tolerant Allograft Recipients
Conditions: Kidney Transplant;   Liver Transplant
Intervention: Procedure: Blood Draw
32 Recruiting Study of the Inflammation and Airway Changes That Occur After Exposure to Allergen in Asthmatics
Condition: Asthma
Intervention: Biological: Segmental airway allergen challenge
33 Recruiting School Inner-City Asthma Intervention Study (SICAS-2)
Condition: Asthma
Interventions: Other: integrated pest management;   Other: air purifier;   Other: No intervention (control)
34 Recruiting Chitinases and Transforming Growth Factor Beta (TGFB) in Human Asthma
Condition: Asthma
35 Recruiting Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
Conditions: Autoantibody Positive;   Non-diabetic Relatives at Risk for Type 1 Diabetes;   High Risk;   Impaired Glucose Tolerance
Intervention: Drug: Teplizumab
36 Recruiting CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Conditions: Abnormal Glucose Tolerance;   Type 1 Diabetes
Interventions: Drug: CTLA4-Ig (Abatacept);   Drug: Placebo
37 Recruiting Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
Condition: Asthma
Interventions: Drug: omalizumab;   Biological: Rhinovirus (strain 16)
38 Recruiting Pathway to Prevention Study
Condition: Diabetes Mellitus, Type 1
39 Recruiting A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Conditions: Anaphylaxis;   Hypotension;   Bronchospasm;   Angioedema
Interventions: Drug: Epinephrine;   Procedure: Bone Marrow Apsiration;   Drug: Omalizumab (Xolair)
40 Recruiting CLAD Phenotype Specific Risk Factors and Mechanisms.
Condition: Lung Transplant
Interventions: Procedure: Blood Draw;   Procedure: Bronchoscopy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years